JPWO2020115501A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020115501A5
JPWO2020115501A5 JP2021532111A JP2021532111A JPWO2020115501A5 JP WO2020115501 A5 JPWO2020115501 A5 JP WO2020115501A5 JP 2021532111 A JP2021532111 A JP 2021532111A JP 2021532111 A JP2021532111 A JP 2021532111A JP WO2020115501 A5 JPWO2020115501 A5 JP WO2020115501A5
Authority
JP
Japan
Prior art keywords
methyl
hydroxy
azaspiro
decan
carbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021532111A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512128A (ja
JP2022512128A5 (https=
Publication date
Priority claimed from GBGB1819937.2A external-priority patent/GB201819937D0/en
Priority claimed from GBGB1904339.7A external-priority patent/GB201904339D0/en
Priority claimed from GBGB1911311.7A external-priority patent/GB201911311D0/en
Application filed filed Critical
Priority claimed from PCT/GB2019/053457 external-priority patent/WO2020115501A1/en
Publication of JP2022512128A publication Critical patent/JP2022512128A/ja
Publication of JP2022512128A5 publication Critical patent/JP2022512128A5/ja
Publication of JPWO2020115501A5 publication Critical patent/JPWO2020115501A5/ja
Pending legal-status Critical Current

Links

JP2021532111A 2018-12-06 2019-12-06 医薬化合物およびユビキチン特異的プロテアーゼ19(usp19)阻害剤としてのその使用 Pending JP2022512128A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB1819937.2 2018-12-06
GBGB1819937.2A GB201819937D0 (en) 2018-12-06 2018-12-06 Pharmaceutical compounds
GBGB1904339.7A GB201904339D0 (en) 2019-03-28 2019-03-28 Pharmaceutical compounds
GB1904339.7 2019-03-28
GB1911311.7 2019-08-07
GBGB1911311.7A GB201911311D0 (en) 2019-08-07 2019-08-07 Pharmaceutical compounds
PCT/GB2019/053457 WO2020115501A1 (en) 2018-12-06 2019-12-06 Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)

Publications (3)

Publication Number Publication Date
JP2022512128A JP2022512128A (ja) 2022-02-02
JP2022512128A5 JP2022512128A5 (https=) 2023-01-11
JPWO2020115501A5 true JPWO2020115501A5 (https=) 2023-01-11

Family

ID=68887435

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021532111A Pending JP2022512128A (ja) 2018-12-06 2019-12-06 医薬化合物およびユビキチン特異的プロテアーゼ19(usp19)阻害剤としてのその使用

Country Status (12)

Country Link
US (1) US20220033397A1 (https=)
EP (1) EP3890829A1 (https=)
JP (1) JP2022512128A (https=)
KR (1) KR20210102285A (https=)
CN (1) CN113365696A (https=)
AU (1) AU2019393162A1 (https=)
BR (1) BR112021010644A2 (https=)
CA (1) CA3121376A1 (https=)
IL (1) IL283706A (https=)
MX (1) MX2021006540A (https=)
SG (1) SG11202105913RA (https=)
WO (1) WO2020115501A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201801562D0 (en) * 2018-01-31 2018-03-14 Almac Diagnostics Ltd Pharmaceutical compounds
GB202104097D0 (en) 2021-03-24 2021-05-05 Almac Discovery Ltd Pharmaceutical compounds
GB202311227D0 (en) 2023-07-21 2023-09-06 Almac Discovery Ltd Pharmaceutical compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO111096A0 (en) * 1996-07-18 1996-08-08 Fujisawa Pharmaceutical Co., Ltd. New compound
ES2309206T3 (es) 2001-10-02 2008-12-16 Smithkline Beecham Corporation Compuestos quimicos.
EP2565186A1 (en) * 2011-09-02 2013-03-06 Hybrigenics S.A. Selective and reversible inhibitors of ubiquitin specific protease 7
MA41291A (fr) * 2014-12-30 2017-11-07 Forma Therapeutics Inc Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
AR103297A1 (es) * 2014-12-30 2017-05-03 Forma Therapeutics Inc Pirrolo y pirazolopirimidinas como inhibidores de la proteasa 7 específica de ubiquitina
EP3253765A1 (en) * 2015-02-05 2017-12-13 Forma Therapeutics, Inc. Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
HK1248220A1 (zh) * 2015-02-05 2018-10-12 Forma Therapeutics, Inc. 喹唑啉酮和偶氮喹唑啉作为泛特丁胺蛋白酶7抑制剂
US9938300B2 (en) * 2015-02-05 2018-04-10 Forma Therapeutics, Inc. Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
FR3052452B1 (fr) * 2016-06-10 2018-06-22 Les Laboratoires Servier Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA3027008C (en) * 2016-06-10 2021-02-09 Les Laboratoires Servier (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
GB201612938D0 (en) * 2016-07-26 2016-09-07 Almac Discovery Ltd Pharmaceutical compounds
GB201801562D0 (en) * 2018-01-31 2018-03-14 Almac Diagnostics Ltd Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
US12281101B2 (en) Bicyclic lactams and methods of use thereof
AU2019216728B2 (en) Heteroaryl pyridone and aza-pyridone compounds as inhibitors of Btk activity
US9963462B2 (en) Sepiapterin reductase inhibitors
KR102003532B1 (ko) 새로운 (헤테로)아릴-치환된-피페리디닐 유도체, 이의 제조를 위한 방법 및 이를 함유하는 약학적 조성물
AU2016291676B2 (en) Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
JP6123804B2 (ja) 3環性ヘテロ環化合物及びjak阻害剤
AU2010310595B2 (en) Disubstituted octahy - dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
RU2020127848A (ru) Производные 4-гидроксипиперидина и их применение в качестве ингибиторов убиквитин-специфической протеазы 19 (usp19)
JP2021525220A5 (https=)
AU2023356610A1 (en) Tethered heterocyclic inhibitors of kras g12c mutant proteins and uses thereof
JP2016525092A5 (https=)
JP2015522002A5 (https=)
JP2018500376A5 (https=)
JP2014506929A5 (https=)
JP2018527353A5 (https=)
JP2016533385A (ja) アルキニルアルコール及び使用方法
JP2021504380A5 (https=)
HRP20210935T1 (hr) Spojevi 5-kloro-2-difluorometoksifenil pirazolopirimidina koji predstavljaju inhibitore jak
JP2017518326A5 (https=)
HRP20250272T1 (hr) Derivati benzimidazola i njihova uporaba
JPWO2022147246A5 (https=)
JPWO2020115501A5 (https=)
JPWO2019150119A5 (https=)
RU2021119602A (ru) Фармацевтические композиции и их применение в качестве ингибиторов убиквитин-специфической протеазы 19 (usp19)
JP2022508523A5 (https=)